Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTI.L Regulatory News (CTI)

  • There is currently no data for CTI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of SGM

4 Dec 2009 11:16

RNS Number : 5984D
Cathay International Holdings Ld
04 December 2009
 



CATHAY INTERNATIONAL HOLDINGS LTD.

Result of Special General Meeting

Shareholders approve overwhelmingly the £26.8 million (net) Placing and Open Offer

FOR PUBLICATION IN THE UNITED KINGDOM ONLY. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA AND JAPAN, OR INTO ANY OTHER JURISDICTION WHERE THE EXTENSION OR AVAILABILITY OF THE PLACING AND OPEN OFFER WOULD BREACH ANY APPLICABLE LAW.

4 December 2009: Cathay International Holdings Ltd. (LSE: CTI.L) ("Cathay" or the "Company"), a company investing primarily in the growing pharmaceutical and healthcare sectors in the People's Republic of Chinaannounces today that the Resolutions required for implementation of the Placing and Open Offer announced on 18 November 2009 were approved overwhelmingly today at a Special General Meeting of shareholders.

Cathay announced on 18 November 2009 that it was proposing to raise approximately £26.8 million (US$45.0 million) net of expenses through a Placing and Open Offer of 101,632,670 New Common Shares at a price of 27.5 pence per New Common Share. 

At the Special General Meeting held earlier today, all the Resolutions that were set out in the Notice of General Meeting included in the Prospectus published on 18 November 2009 were duly passed. 

The results of the Placing and Open Offer were announced earlier today (4 December 2009). 

The final step in the process to complete the Placing and Open Offer is for the New Common Shares to be admitted to trading on the London Stock Exchange and to listing on the Official List of the UK Listing Authority, which is expected to become effective at 8.00 a.m. on 7 December 2009

Wu Zhen Tao, Chief Executive Officer of Cathay, commented:

"We are delighted that our shareholders and a number of new investors share our view of the considerable potential in the PRC for Cathay. We thank them for their support and look forward to delivering excellent growth in shareholder value as we grow our existing business and identify new opportunities."

Capitalised terms used (but not defined) in this announcement have the same meanings as in the Prospectus sent to shareholders on 18 November 2009 unless the context requires otherwise. 

Enquiries

Cathay International Holdings Ltd.
+ 852 2828 9289
Stephen Hunt / Patrick Sung / Eric Siu
 
 
 
Piper Jaffray Ltd.
+44 (0)20 3142 8700
Jamie Adams / Tom Rider
 
 
 
Brunswick
+44 (0)20 7404 5959
Jon Coles 
 

Piper Jaffray Ltd., which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for the Company as financial adviser, sponsor and broker in connection with the Placing and Open Offer and not for any other person and will not be responsible to any other person for providing the protections afforded to its customers or for providing advice in relation to the Placing and Open Offer or any other transaction or arrangement referred to in the Prospectus, the contents of the Prospectus and, if relevant, the accompanying documents or any arrangements referred to therein.

This news release has been issued by Cathay International Holdings Ltd. and is the sole responsibility of Cathay International Holdings Ltd.

The Placing and Open Offer remains conditional upon the Placing Agreement becoming unconditional in all respects (save for the condition relating to Admission) and upon Admission.

This announcement does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities and should not be relied upon in connection with any decision to subscribe for or acquire any New Common Shares.

The distribution of this announcement in certain jurisdictions may be restricted by law and such distribution could result in violation of the laws of such jurisdictions. In particular, this announcement is not for distribution in the United StatesAustraliaCanadaJapan or South Africa.

This announcement is not an offer of securities for sale in the United States. The New Common Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or under the applicable securities laws of any state or other jurisdiction of the United States or qualified for distribution under any applicable securities laws in Canada, Australia, South Africa or Japan. The New Common Shares may not be offered or sold, directly or indirectly, within the United States absent registration or an exemption from registration under the Securities Act and in compliance with any applicable securities laws of the states of the United States. No public offering of the securities discussed herein is being made in the United States and the information contained herein does not constitute an offering of securities for sale in the United StatesAustraliaCanadaJapan or South Africa. This announcement is not for distribution directly or indirectly in or into the United StatesAustraliaCanadaJapan or South Africa.

Neither the New Common Shares, the related Prospectus, this announcement nor any other document connected with the Placing and Open Offer have been or will be approved or disapproved by the United States Securities and Exchange Commission or by the securities commissions of any state or other jurisdiction of the United States or any other regulatory authority, nor have any of the foregoing authorities or any securities commission passed upon or endorsed the merits of the offering of the New Common Shares. Any representation to the contrary is a criminal offence.

The delivery of this announcement shall not, under any circumstances, create any implication that there has been no change in the affairs of the Company since the date of this announcement nor that the information in it is correct as of any subsequent time. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCTIBLTMMAMMIL
Date   Source Headline
2nd Apr 20157:00 amRNSGrant of Share Options
30th Mar 20157:35 amRNSRepeat of Annual Results Announcement RNS 7096I
27th Mar 201512:14 pmRNSAnnual Results for the Year Ended 31 December 2014
25th Mar 20157:00 amRNSHolding(s) in Company
12th Mar 20157:00 amRNSNotice of Annual Results 2014
5th Jan 20159:16 amRNSLansen's New Distribution Agreement
18th Dec 20148:36 amRNSLansen and Haotian Renew Supply Agreement
29th Aug 20149:26 amRNSInterim results for six months ended 30 June 2014
19th Aug 20147:00 amRNSNotice of Interim Results 2014
23rd May 201410:38 amRNSResult of AGM
19th May 20147:00 amRNSInterim Management Statement
7th Apr 20148:58 amRNSGrant of Share Options
31st Mar 20147:00 amRNSAcquisition of Sicorten Plus in the PRC
28th Mar 20148:47 amRNSAnnual Results for the Year Ended 31 December 2013
14th Mar 20147:00 amRNSNotice of Annual Results
19th Nov 20137:00 amRNSInterim Management Statement
15th Oct 201310:24 amRNSTransfer of Misoprostol Development Project
3rd Sep 20131:31 pmRNSLansen and Haotian Sign Supply Agreement
30th Aug 20139:42 amRNSInterim Results for the six months ended June 2013
19th Aug 20139:24 amRNSNotice of Interim Results
21st May 20137:00 amRNSResults of Annual General Meeting
16th May 20137:00 amRNSInterim Management Statement
11th Apr 20137:00 amRNSAnnual Report and Accounts
4th Apr 20139:03 amRNSGrant of Share Options
27th Mar 20138:30 amRNSAnnual Results for the Year Ended 31 December 2012
14th Mar 20139:33 amRNSNotice of Annual Results 2012
6th Mar 20138:30 amRNSCathay's subsidiary Lansen board change
26th Feb 201310:37 amRNSTR-1: Notification of Major Interest in Shares
23rd Nov 20128:55 amRNS1.5% holding in Zhejiang Starry Pharmaceutical Co.
19th Nov 20127:00 amRNSInterim Management Statement
29th Aug 201212:15 pmRNSTotal Voting Rights and Share Capital
29th Aug 20129:23 amRNSInterim results
15th Aug 20127:00 amRNSNotice of Interim Results
25th May 201211:26 amRNSResult of AGM
21st May 20127:00 amRNSAnnual Information Update
17th May 20127:00 amRNSInterim Management Statement
10th May 20127:00 amRNSLicense for collagen injectable filler
20th Apr 20129:15 amRNSAnnual Report and Accounts
3rd Apr 201210:50 amRNSGrant of Share Options
29th Mar 20129:32 amRNSAnnual Results for the Year Ended 31 December 2011
19th Mar 201210:00 amRNSNotification of Annual Results
27th Feb 20129:43 amRNSLansen Received Technology Endorsement
9th Jan 20129:00 amRNSLansen signs exclusive agreement
18th Nov 20117:00 amRNSInterim Management Statement
26th Oct 20119:47 amRNSLansen signs exclusive agreement with Ethypharm
25th Aug 20115:00 pmRNSInterim Results
15th Aug 201111:12 amRNSNotice of Interim Results
20th May 20117:00 amRNSAnnual Information Update
19th May 20117:00 amRNSInterim Management Statement
6th Apr 20117:00 amRNSTotal Voting Rights and Share Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.